期刊文献+

GnRH拮抗剂方案与GnRH激动剂长方案在PCOS患者行IVF-ET的比较 被引量:13

IVF-ET Outcome Comparison Between GnRH Antagonist Protocol and GnRH Agonist Long Protocol in Treating PCOS Patients
在线阅读 下载PDF
导出
摘要 目的比较不同促排卵方案在多囊卵巢综合征(PCOS)患者行体外受精-胚胎移植(IVF-ET)中的应用效果。方法 104例PCOS患者随机分为两组:促性腺激素释放激素(GnRH)拮抗剂组41例和GnRH激动剂长方案(对照组)63例,统计比较两组促性腺激素(Gn)的用量及用药天数、人绒毛膜促性腺激素(HCG)日的雌二醇(E2)、黄体生成素(LH)水平、获卵数、受精率、卵裂率、优胚率、种植率、临床妊娠率、周期取消率和卵巢过度刺激综合征(OHSS)的发生率。结果两组的获卵数、受精率、卵裂率、优胚率、临床妊娠率、种植率比较均无明显差异(P>0.05);GnRH拮抗剂组的Gn使用量及天数均少于对照组(P<0.05);GnRH拮抗剂组HCG日的E2水平低于对照组(P<0.05);GnRH拮抗剂组HCG日LH水平高于对照组(P<0.05);GnRH拮抗剂组的周期取消率4.88%低于对照组的25.40%(P<0.05),GnRH拮抗剂组的OHSS发生率2.44%低于对照组的12.70%(P>0.05)。结论 GnRH拮抗剂方案较GnRH激动剂长方案能减少周期取消率、降低OHSS发生风险,而获卵数、受精率、卵裂率、优胚率、临床妊娠率、种植率方面不受影响;GnRH拮抗剂方案能缩短治疗时间、减少治疗费用,具有较好的安全性和有效性,对PCOS患者行IVF-ET是一种比较理想的选择。 Objective To compare in vitro fertilization and embryo transfer (IVF-ET) outcome of gonadotropin- releasing hormone (GnRH) antagonist protocol and GnRH agonist long protocol in patients with polycystic ovary syndrome (PCOS) and to provide reference for rational selection of ovulation stimulation protocol for PCOS patients. Methods One hundred and four patients with PCOS who underwent IVF-ET were randomly divided into two groups. In the study group, 41 patients were subjected to the GnRH antagonist protocol;In the control group,63 patients were subjected to a long protocol of GnRH agonist. Doses and duration of gonadotropin therapy,the thickness of endometrium and the profile of hormone level on the day of HCG administration, the number of retrieved oocytes, the ratio of fertilization, the ratio of cleavage, the ratio of the good quantity embryos, implantation rate of embryo, pregnancy rate, the cycle cancellation rate and the incidence rate of ovarian hyperstimulation syndrome (OHSS) were recorded. Results The IVF-ET outcome of the two groups was similar with respects to the number of oocytes ,the ratio of fertilization, the ratio of cleavage, implantation rate of embryo and the pregnancy rate ( P〉 0.05 ). Significant differences were found ( P〈0.05 ) between the two groups regarding to the doses and duration of gonadotropin therapy,the levels of serum E2 and LH on the day of HCG administration, and the cycle cancellation rate. The incidence rate of OHSS was not significantly different (2. 44% vs. 12. 70% ) between the two groups. Conclusion The duration of gonadotropins administration,the cycle cancellation rate, incidence of OHSS and the financial burdern are reduced in patients treated with GnRH antagonist. The growth of follicle, the ratio of fertilization, the ratio of cleavage, implantation rate of embryo and the pregnancy rate are not different between the two methods. The GnRH antagonist protocol is optimal for patients with PCOS.
出处 《医药导报》 CAS 北大核心 2014年第6期735-739,共5页 Herald of Medicine
基金 南宁市科技攻关与新产品试制(201106045C) 广西壮族自治区卫生厅自筹经费科研课题(Z2011152)
关键词 GNRH拮抗剂 GNRH激动剂 综合征 多囊卵巢 体外受精-胚胎移植 综合征 卵巢过度刺激 GnRH antagonist GnRH agonist Syndrome, polycystic ovary Transfer, in vitro fertilization and embryo Syndrome, ovarian hyperstimulation
作者简介 谭秀群(1970-),女,广西都安人,副主任医师,学士,研究方向:生殖临床。电话:(0)15977190303,E—mail:tanxiuqungx@126.com。
  • 相关文献

参考文献9

  • 1陈子江.多囊卵巢综合征相关病因及临床研究——来自山东大学生殖医学中心的报告[J].生殖医学杂志,2007,16(4):232-235. 被引量:45
  • 2罗金,杨菁.1例生育期多囊卵巢综合征患者的循证治疗[J].医药导报,2010,29(6):711-714. 被引量:1
  • 3The Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [ J ]. Hum Reprod ,2004,19 ( 1 ) :41-47.
  • 4PORTER R N, SMITH W, CRAFT I L, et al. Induction of ovulation for in-vitro fertilization using buserelin and gonadotropins [ J ]. Lancet, 1984,2 ( 8414 ) : 1284-1285.
  • 5谭秀群,丘映.促性腺激素释放激素拮抗剂在辅助生殖技术中的应用研究进展[J].医学综述,2012,18(18):2937-2940. 被引量:4
  • 6STADMAUER L A, KARIYA K, ARSLAN M, et al . Impact of a GnRH antagonist (Canirelix)on the outcome of controlled ovarian hyperstimulation (COH) in PCOS patients: a prospective and randomized study [ J ]. Fertil Steril,2005,84( Suppll ) :314.
  • 7LAINAS T G, SFONTOURIS ! A, ZORZOVILIS I Z, et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT) [ J ]. Hum Reprod ,2010,25 (3) :683-689.
  • 8RAGNI G, VEGETFI W, RICCABONI A, et al. Comparison of GnRH agonists and antagonists in assisted reproduction cycles of patients at high risk of ovarian hypertimulation syndrome [ J ]. Human Reprod ,2005,20 (9) : 2421-2425.
  • 9KURZAWA R, CIEPIELA P, BACZKOWSKI T, et al. Com- parison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients, a prospective randomized study [ J ]. Assist Reprod Genet, 2008,25 ( 8 ) :365-374.

二级参考文献89

共引文献47

同被引文献136

引证文献13

二级引证文献76

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部